Anti-imperfections efficacy from 8H proven on more than 13 000 acne patients.
EFFACLAR DUO+M:
- -57% inflammatory lesions on day 281
- -56% retentional lesions on day 282
- Corrects and prevents marks, with -42% post-inflammatory hyperpigmentation on day 561
- 3 months anti-relapse3
115 patients, phototypes, Ill to V. 2/day. Half-face DUO(+), Half-face placebo. Lesion count at D28 & D56.
2Clinical study, 45 patients, 1/day effaclar duo(+) & effaclar foaming gel 2/day, 4 weeks.
3Clinical study, 3 months, 25 subjects with Effaclar duo(+) after BPO.